These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17346631)

  • 21. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study.
    Lütjohann D; von Bergmann K; Sirah W; Macdonell G; Johnson-Levonas AO; Shah A; Lin J; Sapre A; Musliner T
    Int J Clin Pract; 2008 Oct; 62(10):1499-510. PubMed ID: 18822021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezetimibe in heart transplantation: initial experience.
    Moro J; Almenar L; Martínez-Dolz L; Izquierdo M; Agüero J; Sánchez-Lazaro I; Ortiz V; Salvador A
    Transplant Proc; 2007 Sep; 39(7):2389-92. PubMed ID: 17889199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of thrice weekly ezetimibe.
    Venero CV; Venero JV; Seip RL; Thompson PD
    Am J Cardiol; 2008 Nov; 102(9):1205-6. PubMed ID: 18940292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population.
    Puthenparumpil JJ; Keough-Ryan T; Kiberd M; Lawen J; Kiberd BA
    Transplant Proc; 2005 Mar; 37(2):1033-5. PubMed ID: 15848614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
    Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
    Pitsavos C; Skoumas I; Tousoulis D; Metalinos G; Masoura C; Chrysohoou C; Papadimitriou L; Giotsas N; Toutouza M; Antoniades C; Stefanadis C
    Int J Cardiol; 2009 May; 134(2):280-1. PubMed ID: 18353459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for cholesterol hyperabsorbers and hyperproducers based on comparative low-density lipoprotein reductions achieved by ezetimibe versus statins.
    Senaratne J; Griffiths J; MacDonald K; Senaratne MP
    J Cardiopulm Rehabil Prev; 2012; 32(5):250-4. PubMed ID: 22785146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myopathy associated with atorvastatin-ezetimibe combination therapy.
    Weffald LA; Flach LA
    Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.
    Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with ezetimibe in kidney transplant recipients with uncontrolled dyslipidemia.
    López V; Gutiérrez C; Gutiérrez E; Sola E; Cabello M; Burgos D; González Molina M
    Transplant Proc; 2008 Nov; 40(9):2925-6. PubMed ID: 19010149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.
    Quarta CC; Potena L; Grigioni F; Scalone A; Magnani G; Coccolo F; Fallani F; Russo A; Branzi A
    J Heart Lung Transplant; 2008 Jun; 27(6):685-8. PubMed ID: 18503971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies.
    Knopp RH; Dujovne CA; Le Beaut A; Lipka LJ; Suresh R; Veltri EP;
    Int J Clin Pract; 2003 Jun; 57(5):363-8. PubMed ID: 12846338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
    J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supratherapeutic response to ezetimibe administered with cyclosporine.
    Koshman SL; Lalonde LD; Burton I; Tymchak WJ; Pearson GJ
    Ann Pharmacother; 2005 Sep; 39(9):1561-5. PubMed ID: 16030077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors.
    Langone AJ; Chuang P
    Transplantation; 2006 Mar; 81(5):804-7. PubMed ID: 16534487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.